Advanced Search
Home In the Journal Supplements 2007 April
Subscriptions
Home
In the Journal
AOP
Supplements
Special issues
Rapid Dispatches
Archive
News
Virtual Symposium
Protocols
Posters
MultiMedia
BioMarket
Community
Subscribe
About BioTechniques
Advertise
Sign Up to BioTechniques free email alert service to receive content updates.
Supplement | April 2007
Volume:42 , Issue Number:4
Cover Image:
Is Big Pharma Ready to Deliver?
Pharma Profiles
Three researchers developing therapies based on RNA interference talk about their experiences leaving academia for biotech companies.
Laura Bonetta
BioTechniques, Vol. 42, No. S4, April 2007, pp. S10–S11, S16
doi  10.2144/000112433
 
Perspective on the Industry
To make better therapeutics, companies strive to increase the content of results and get them faster.
Michael Szpir
BioTechniques, Vol. 42, No. S4, April 2007, pp. S3–S5
doi  10.2144/000112432
 
Technology Review
Lab studies and early clinical trials suggest that RNAi could become a potent new approach to treating many medical conditions, including autoimmune diseases, cancer, influenza, and more.
Mike May
BioTechniques, Vol. 42, No. S4, April 2007, pp. S7–S9, S16
doi  10.2144/000112431
 
Career Outlook
The inside story on landing a top job in the pharmaceutical industry.
David Schoonmaker
BioTechniques, Vol. 42, No. S4, April 2007, pp. S12–S14
doi  10.2144/000112430
 

 
submit papers submit covers reprints advertise permissions sitemap subscriptions
privacy terms & conditions feedback contact us © 1983-2010 BioTechniques